We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
12 hedge funds and large institutions have $2.7M invested in Cyclo Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
361% more capital invested
Capital invested by funds: $585K → $2.7M (+$2.11M)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
33% more funds holding
Funds holding: 9 → 12 (+3)
Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$987K |
| 2 |
State Street
Boston,
Massachusetts
|
+$374K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$204K |
| 4 |
BlackRock
New York
|
+$90.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$87K |
Top Sellers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$141K |